Search research articles
Contact Us
Filters
Showing results (711-720 of 818) with videos related to
Page
of 82
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 3, 1999
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection
R E Lewis, M E Klepser, E J Ernst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
D J Diekema, M A Pfaller, F J Schmitz, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years
S A Marshall, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology
|
May 1, 1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin
M E Erwin, R N Jones, F P Koontz, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 1996
Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottles
W J Howard, B J Buschelman, M J Bale, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
R N Jones, P C Fuchs, A L Barry, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 20, 2001
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program
H S Sader, A C Gales, M A Pfaller, et al.
Journal of Clinical Microbiology
|
December 8, 2006
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program
H Aboufaycal, H S Sader, K Rolston, et al.
Diagnostic Microbiology and Infectious Disease
|
June 19, 2001
Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients
J L Burns, L Saiman, S Whittier, et al.
Genome
|
August 1, 1993
Identification of the E3900 family, a second family of rye B chromosome specific repeated sequences
R Blunden, T J Wilkes, J W Forster, et al.
Page
of 82
Search research articles
Search
Showing results (711-720 of 818) with videos related to
Sort By:
Page
of 82
Antimicrobial Agents and Chemotherapy
|
August 3, 1999
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection
R E Lewis, M E Klepser, E J Ernst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2001
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999
D J Diekema, M A Pfaller, F J Schmitz, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1995
Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A reevaluation after five years
S A Marshall, K E Aldridge, S D Allen, et al.
Journal of Clinical Microbiology
|
May 1, 1992
MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin
M E Erwin, R N Jones, F P Koontz, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 1996
Vitek GPS card susceptibility testing accuracy using direct inoculation from BACTEC 9240 blood culture bottles
W J Howard, B J Buschelman, M J Bale, et al.
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates
R N Jones, P C Fuchs, A L Barry, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 20, 2001
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program
H S Sader, A C Gales, M A Pfaller, et al.
Journal of Clinical Microbiology
|
December 8, 2006
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program
H Aboufaycal, H S Sader, K Rolston, et al.
Diagnostic Microbiology and Infectious Disease
|
June 19, 2001
Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients
J L Burns, L Saiman, S Whittier, et al.
Genome
|
August 1, 1993
Identification of the E3900 family, a second family of rye B chromosome specific repeated sequences
R Blunden, T J Wilkes, J W Forster, et al.
Page
of 82